Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

Molecular Psychiatry

Volumn 14, Issue 1, 2009, Pages 30-36

  O'Donovan, M C ^a   Norton, N ^a   Williams, H ^a   Peirce, T ^a   Moskvina, V ^a   Nikolov, I ^a   Hamshere, M ^a   Carroll, L ^a   Georgieva, L ^a   Dwyer, S ^a   Holmans, P ^a   Marchini, J L ^b   Spencer, C C A ^b   Howie, B ^b   Leung, H T ^c   Giegling, I ^d   Hartmann, A M ^d   Moller H J ^e   Morris, D W ^f   Shi, Y ^g   Feng, G ^h   Hoffmann, P ⁱ   Propping, P ⁱ   Vasilescu, C ⁱ   Maier, W ⁱ   Rietschel, M ^j   Zammit, S ^a   Schumacher, J ^k   Quinn, E M ^f   Schulze, T G ^k   Iwata, N ^l,m   Ikeda, M ^l,m   Darvasi, A ⁿ   Shifman, S ⁿ   He, L ^g,o   Duan, J ^p,q   Sanders, A R ^p,q   Levinson, D F ^r,u   Adolfsson, R ^s   Osby U ^t   Terenius, L ^t   Jonsson E G ^t   Cichon, S ⁱ   Nothen M M ⁱ   Gill, M ^f   Corvin, A P ^f   Rujescu, D ^d   Gejman, P V ^p,q   Kirov, G ^a   Craddock, N ^a   Williams, N M ^a   Owen, M J ^a   Buccola, N G ^v   Mowry, B J ^w   Freedman, R ^x   Amin, F ^y   Black, D W ^z   Silverman, J M ^aa   Byerley, W J ^ab   Cloninger, C R ^ac   more..

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF MUNICH   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g SHANGHAI JIAO TONG UNIVERSITY   (China)

^h SHANGHAI MENTAL HEALTH CENTER   (China)

ⁱ UNIVERSITY OF BONN   (Germany)

^j CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^k NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^l FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

ⁿ HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^o Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^p NORTHWESTERN UNIVERSITY   (United States)

^q NORTHWESTERN UNIVERSITY   (United States)

^r STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UMEÅ UNIVERSITY   (Sweden)

^t KAROLINSKA INSTITUTE   (Sweden)

^u STANFORD UNIVERSITY   (United States)

^v LOUISIANA STATE UNIVERSITY   (United States)

^w UNIVERSITY OF QUEENSLAND   (Australia)

^x UNIVERSITY OF COLORADO   (United States)

^y EMORY UNIVERSITY   (United States)

^z UNIVERSITY OF IOWA   (United States)

^aa MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

FGFR2; Genome wide association study; Schizophrenia

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ARTICLE; CHINA; CHROMOSOME 10Q; CONTROLLED STUDY; DNA FLANKING REGION; GENE REPLICATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; HUMAN; ISRAEL; JAPAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SCHIZOPHRENIA; YOUNG ADULT;

EID: 58049218976     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2008.108     Document Type: Article

References (38)

1. Gottesman II. Schizophrenia Genesis, The Origins of Madness. WH Freeman and Company: New York, 1991.
2. Cardno A, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000; 97: 12-17.
3. Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 1990; 7: 3-16.
4. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34-48.
5. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415-1423.
6. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-348.
7. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83-87.
8. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-13680.
9. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V et al. Identification of novel schizophrenia loci by genome-wide association and follow-up. Nat Genet 2008; 40: 1053-1055.
10. Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008; 17: 458-465.
11. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543.
12. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008; 40: 880-885.
13. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455: 232-236.
14. The International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241.
15. Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, Lindblom Yet al. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet 2003; 73: 1355-1367.
16. Mowry BJ, Ewen KR, Nancarrow DJ, Lennon DP, Nertney DA, Jones HL et al. Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Am J Med Genet 2000; 96: 864-869.
17. Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 2001; 98: 585-590.
18. Cichon S, Schmidt-Wolf G, Schumacher J, Müller DJ, Hürter M, Schulze TG et al. A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25-q26. Mol Psychiatry 2001; 6: 342-349.
19. Lerer B, Segman RH, Hamdan A, Kanyas K, Karni O, Kohn Yet al. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol Psychiatry 2003; 8: 488-498.
20. Liu J, Juo SH, Dewan A, Grunn A, Tong X, Brito M et al. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol Psychiatry 2003; 8: 333-342.
21. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 2006; 78: 315-333.
22. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A et al. Genome scan of schizophrenia. Am J Psychiatry 1998; 155: 741-750.
23. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32: 9-16.
24. Ewald H, Flint TJ, Jorgensen TH, Wang AG, Jensen P, Vang M et al. Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. Am J Med Genet 2002; 114: 196-204.
25. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
26. Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, Kulle B, Frigessi A et al. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 924-933.
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
28. Moskvina V, Schmidt KM. On multiple-testing correction in genome-wide association studies. Genet Epidemiol 2008; 32: 567-573.
29. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008; 32: 227-234.
30. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007; 315: 848-853.
31. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L et al. A survey of genetic human cortical gene expression. Nat Genet 2007; 39: 1494-1499.
32. Alzheimer C, Werner S. Fibroblast growth factors and neuroprotection. Adv Exp Med Biol 2002; 513: 335-351.
33. Umemori H, Linhoff MW, Ornitz DM, Sanes JR. FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell 2004; 118: 257-270.
34. Turner CA, Akil H, Watson SJ, Evans SJ. The fibroblast growth factor system and mood disorders. Biol Psychiatry 2006; 59: 1128-1135.
35. Riva MA, Molteni R, Bedogni, Racagni G, Fumagalli F. Emerging role of the FGF system in psychiatric disorders. Trends Pharmacol Sci 2005; 26: 228-231.
36. Hashimoto K, Shimizu E, Komatsu N, Nakazato M, Okamura N, Watanabe H et al. Increased levels of serum basic fibroblast growth factor in schizophrenia. Psychiatry Res 2003; 120: 211-218.
37. Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry MI. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull 2006; 70: 221-227.
38. Klejbor I, Myers JM, Hausknecht K, Corso TD, Gambino AS, Morys J et al. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice. J Neurochem 2006; 97: 1243-1258.